Gene Therapy for Alzheimer's Disease - Brigham and Women's Hospital EP3976637
Summary
The European Patent Office published patent application EP3976637A1, filed by The Brigham and Women's Hospital, Inc. and The General Hospital Corporation, covering a gene therapy approach for treating Alzheimer's disease. The invention, developed by inventors Shen Jie and Kelleher III Raymond J., is classified under C12N 15/86 and related protein classification C07K 14/47. The patent is designated across all EU member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.
What changed
The EPO published patent EP3976637A1 for a gene therapy method targeting Alzheimer's disease, with inventors Shen Jie and Kelleher III Raymond J., assigned to The Brigham and Women's Hospital, Inc. and The General Hospital Corporation. The patent covers the therapeutic composition and method of use classified under C12N 15/86.
Affected parties in the biotechnology and pharmaceutical sectors should monitor this patent landscape for freedom-to-operate considerations, as the granted claims may restrict development of competing gene therapy approaches for Alzheimer's disease within EU member states.
What to do next
- Monitor patent register for potential infringement implications
- Review licensing opportunities for gene therapy technology
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
GENE THERAPY FOR ALZHEIMER'S DISEASE
Publication EP3976637A1 Kind: A1 Apr 08, 2026
Applicants
The Brigham and Women's Hospital, Inc., The General Hospital Corporation
Inventors
SHEN, Jie, KELLEHER III, Raymond J.
IPC Classifications
C07K 14/47 20060101AFI20230515BHEP C12N 15/67 20060101ALI20230515BHEP C12N 15/86 20060101ALI20230515BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.